Erenumab Biosimilar – Anti-CALCRL, CGRP-R mAb – Research Grade

Reference:
Size

,

Isotype

IgG2-lambda

Brand

Product type

Clonality

Expression system

Applications

,

Product nameErenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade
SourceCAS 1582205-90-0
SpeciesHomo sapiens
Expression systemMammalian cells
Molecular weight150 kDa
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsErenumab,AMG 334,erenumab-aooe,CALCRL, CGRP-R,anti-CALCRL, CGRP-R
ReferencePX-TA1427
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-lambda
ClonalityMonoclonal Antibody

Description of Erenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade

General information on Anti-CALCRL/CGRP-R[Homo sapiens] (Erenumab) Monoclonal Antibody

Erenumab is a human monoclonal antibody that targets the calcitonin gene-related peptide receptor (CGRPR). It has been used to prevent migraines. Erenumab has been sold under the trade name Aimovig.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Erenumab Biosimilar – Anti-CALCRL, CGRP-R mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products